Generated October 29, 2026 at 6:30 PM ET
· Covers October 29 trading day
· 10 of 454 ready 8-Ks selected
· AI-assisted overview
The highest-materiality filings centered on two announced take-private and acquisition deals: ADT agreed to be acquired by Thrive Holdings for $10.00 per share in cash, while DoorDash agreed to acquire Maplebear (Instacart) in a cash-and-stock transaction. The Maplebear disclosure appeared in two cards covering the same transaction, one focused on deal terms and termination fees and the other on the accompanying quarterly results. Two Nasdaq delistings were also reported, for Glucotrack after a bid-price shortfall and for Aldel Financial II after a listing-rule failure, alongside BCB Bancorp's large Q3 loss driven by a $115 million credit provision and problem-loan sales. Earnings filings from Sandisk and Monolithic Power Systems described strong year-over-year revenue growth, and the remaining items were Rafael Holdings' NDA submission for remibetadex in Niemann-Pick Disease Type C and a Unified Patent Court ruling invalidating an Enanta patent and dismissing its Paxlovid infringement action.
regulatory
negative
materiality 0.85
October 29, 2026, 5:00 PM ET
Glucotrack delisted by Nasdaq after $0.87 close violates bid-price exception; trading halted Oct 30
- Nasdaq Hearings Panel required a closing bid of at least $1.00 every trading day through November 9, 2026; company closed at $0.87 on October 14, 2026.
- Trading in Glucotrack common stock (GCTK) on Nasdaq will be suspended at the open of trading on October 30, 2026.
- Nasdaq expected to file Form 25 to delist the securities and deregister them under Section 12(b) of the Exchange Act.
M&A
positive
materiality 0.98
October 29, 2026, 9:23 AM ET
Thrive Holdings to acquire ADT for $15.3 billion in all-cash deal at $10.00 per share
- ADT stockholders will receive $10.00 per share cash, a 45.6% premium to the $6.87 unaffected close on Oct. 27, 2026; equity value is about $7.6 billion.
- Thrive Holdings will acquire ADT at about $15.3 billion enterprise value; financing commitments are solely from funds managed by affiliates of Apollo Global Management.
- The deal is expected to close in Q1 2027, subject to ADT stockholder approval and U.S. antitrust approval; it is not subject to a financing condition.
M&A
positive
materiality 0.95
October 29, 2026, 8:32 AM ET
DoorDash to acquire Maplebear (Instacart) in cash-and-stock deal at $65.00 per share
- Per-share consideration: $65.00 cash, or 0.3372 DoorDash Class A shares, or a mixed election of $48.75 cash plus 0.08430 DoorDash shares.
- Stock elections are subject to proration, capped so the aggregate stock portion does not exceed what all holders would get under the Mixed Consideration.
- Maplebear pays a $650M termination fee for a Superior Proposal or adverse recommendation change; DoorDash pays $1.25B in specified regulatory-failure terminations.
RFL
Rafael Holdings, Inc.
regulatory
positive
materiality 0.85
October 29, 2026, 8:16 AM ET
Rafael Holdings submits NDA for remibetadex in NPC; FY2026 net loss narrows to $29.6 million
- Cyclo Therapeutics, a Rafael Holdings subsidiary, submitted an NDA to the FDA for remibetadex (Trappsol Cyclo) in Niemann-Pick Disease Type C on October 28, 2026.
- Phase 3 TransportNPC missed its primary endpoint (p=0.19) but showed 71% slowing of disease progression in patients on background therapy (p=0.046).
- Overall survival analysis showed an 85% reduction in mortality risk for infantile-onset NPC versus matched registry controls (p=0.044); serious adverse events were 35.9% vs 16.7%.
M&A
positive
materiality 1.00
October 29, 2026, 7:38 AM ET
Instacart to be acquired by DoorDash for ~$17B; Q3 revenue $1.1B, GTV up 15%
- DoorDash (NASDAQ: DASH) agreed to acquire Instacart (NASDAQ: CART) in a cash-and-stock transaction with an equity value of approximately $17 billion.
- Q3 2026 GTV was $10,528 million, up 15% YoY; orders rose 10% to 91.4 million; total revenue was $1,095 million, up 17% YoY.
- GAAP net income was $147 million; Adjusted EBITDA was $342 million, up 23% YoY; advertising and other revenue was $331 million, up 23%.
ALDF
Aldel Financial II Inc.
regulatory
negative
materiality 0.75
October 29, 2026, 5:20 PM ET
Aldel Financial II to be delisted from Nasdaq Nov 6; OTC symbols ALDF, ALDFU, ALDFW assigned
- Nasdaq staff determined the securities will be delisted; trading in ordinary shares, warrants and units is suspended at the open on Nov 6, 2026, and a Form 25-NSE will be filed.
- Delisting follows failure to meet Nasdaq Listing Rule 5450(a)(2), flagged to the company Sept 10, 2026; no compliance plan was submitted before Nasdaq's deadline.
- FINRA assigned OTC symbols ALDF (Class A ordinary shares), ALDFU (units) and ALDFW (warrants); quoting in the unlisted market may begin Nov 6, 2026.
earnings
negative
materiality 0.90
October 29, 2026, 7:49 AM ET
BCB Bancorp posts Q3 2026 net loss of $132.5M ($6.92/sh) on $115M credit provision; sells $204.3M of problem loans
- Net loss of $132.5M, or $6.92 per diluted share, vs net income of $3.8M ($0.22) in Q3 2025; provision for credit losses $115.0M vs $4.1M a year ago.
- Sold $204.3M of problem loans ($179.7M commercial/multifamily, $14.6M C&I, $10.0M construction) with $42.3M charge-off; moved $100.9M more to held-for-sale, $44.2M charge-off.
- $59.9M non-cash valuation allowance against deferred tax assets drove income tax provision of $23.5M; nine-month net loss $142.8M ($7.98/sh).
earnings
positive
materiality 0.90
October 29, 2026, 4:13 PM ET
Sandisk Q1 revenue $11.0B, up 378% YoY; GAAP EPS $52.60; 8-for-1 split and $12.2-12.6B Q2 guide
- Revenue $11.03B, up 23% QoQ and 378% YoY; GAAP net income $8.10B ($52.60 diluted EPS), non-GAAP EPS $49.51 (+26% QoQ); GAAP gross margin 85.0%.
- Datacenter revenue $4.80B, up 61% QoQ from $2.98B; Edge $5.83B (+7% QoQ, +320% YoY); Consumer $397M, down 29% QoQ and 39% YoY.
- Returned $5.0B to stockholders buying back ~3.2M shares in the quarter; 6.0M shares repurchased over two quarters, about 4% of shares outstanding.
MPWR
MONOLITHIC POWER SYSTEMS INC
earnings
positive
materiality 0.88
October 29, 2026, 4:01 PM ET
MPS Q3 revenue tops $1.2B for first time, up 63% YoY; GAAP EPS $5.51, non-GAAP $8.19
- Revenue $1,202.4M, up 22.6% QoQ and 63.1% YoY, first quarter above $1B; GAAP diluted EPS $5.51, non-GAAP $8.19.
- Enterprise Data revenue $506.7M rose 33.2% QoQ and 164.6% YoY, 42.1% of total; Communications $187.4M rose 42.5% QoQ and 134.7% YoY.
- Q4 2026 outlook: revenue $1.315B-$1.385B, non-GAAP gross margin 55.5%-56.1%, GAAP opex $334M-$342M, non-GAAP tax rate 15%.
ENTA
ENANTA PHARMACEUTICALS INC
litigation
negative
materiality 0.60
October 29, 2026, 4:05 PM ET
UPC invalidates Enanta's EP 4 051 265 patent; Paxlovid infringement action against Pfizer dismissed
- Unified Patent Court ruled on October 29, 2026 that European Patent No. EP 4 051 265 is invalid, and that Enanta's infringement action was unfounded in light of that holding.
- Enanta had sued Pfizer and subsidiaries in the UPC over Pfizer's manufacture, use and sale of Paxlovid (nirmatrelvir/ritonavir tablets) across the 18 EU member states participating in the UPC.
- Pfizer counterclaimed for revocation of the '265 Patent; a hearing on both the infringement action and the revocation counterclaim was held September 29, 2026.